Cencora (COR) Stock Is Up, What You Need To Know
Update: 2025-10-30
Description
Cencora's stock surged by 2.6% after a Wall Street analyst raised his price target, signaling confidence in the company's market performance. The move follows a strong quarter from competitor Cardinal Health and a previous boost from McKesson's earnings growth forecast. Cencora's stock has seen a significant run this year, with a 52% increase since January and a new 52-week high. The healthcare distributor sector is experiencing steady growth and optimism, making Cencora an attractive investment opportunity.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




